Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).

Clinical trial NCT05961644 · RECRUITING

Trial details

NCT number: NCT05961644
Sponsor: Institute of Psychiatry and Neurology, Warsaw
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Start date: 2022-10-03
Primary completion: 2027-06-30
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.